/Companies

Biosymetrics

1 known investors

Find your way into Biosymetrics

Sign up to see every warm intro you have to Biosymetrics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Biosymetrics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

BioSymetrics builds an AI/ML and in vivo validation platform that combines clinical records, genomic profiles, and experimental data to identify disease subtypes, biomarkers, and higher-confidence drug targets for precision medicines. It applies this workflow to areas including precision neurology, neuropsychiatry, rare neurological disorders, and biodefence, serving drug discovery and clinical trial optimization.

Investors · 1

Frequently asked questions

What does Biosymetrics do?
BioSymetrics builds an AI/ML and in vivo validation platform that combines clinical records, genomic profiles, and experimental data to identify disease subtypes, biomarkers, and higher-confidence drug targets for precision medicines. It applies this workflow to areas including precision neurology, neuropsychiatry, rare neurological disorders, and biodefence, serving drug discovery and clinical trial optimization.
Who are Biosymetrics's investors?
Biosymetrics's investors include Dasein Capital.